This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers | MicrobiomeTrials
← Back to trials NCT07743593
Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2027-01-05Est. Completion: 2031-08-30
Enrollment target: 505 participantsLocations Infectious Diseases Institute, Makerere University, Kampala, Uganda Other microbiome trials you might be interested in Meningitis
This study will investigate the burden, causes, diagnostics, treatments and preventive measures related to meningitis in…
Lira, Uganda Est. completion Sep 1, 2031
Cryptococcal Meningitis
This will be a randomized controlled trial of asymptomatic (Cryptococcal Antigen test)CrAg positive persons in Uganda.
…
Kampala, Uganda Est. completion Jun 2027